AGL-2043
UNII 8OO2SLF34L

Substance Identification & Data

This profile provides standardized clinical and technical data for Agl-2043, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8OO2SLF34L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 226717-28-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
8OO2SLF34L
CAS Registry Number
226717-28-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
AGL-2043
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C15H12N4S
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
ZGDACLBJJXLKJY-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
n1c(cnc2cc3c(cc12)nc(n3C)C)-c4cccs4

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Agl-2043. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

AGL-2043

Systematic Nomenclature

1H-IMIDAZO(4,5-G)QUINOXALINE, 1,2-DIMETHYL-6-(2-THIENYL)-